Macronutrient composition and sarcopenia in the oldest-old men: The Helsinki Businessmen Study (HBS)
- PMID: 32376097
- DOI: 10.1016/j.clnu.2020.04.024
Macronutrient composition and sarcopenia in the oldest-old men: The Helsinki Businessmen Study (HBS)
Abstract
Background & aim: Sarcopenia is associated with increased risk for several adverse health outcomes including frailty, disability, loss of independence, and mortality. We examined cross-sectional associations between sarcopenia and detailed dietary macronutrient composition in community-living oldest-old men (mean age 87).
Methods: Participants were invited to a clinic visit in 2017/2018 including assessments of sarcopenia status using European Working Group on Sarcopenia in Older People's 2 (EWGSOP2) criteria and detailed macronutrient, vitamin D and food intakes retrieved from 3-day food diaries.
Results: Of the 126 participants, 48 had probable sarcopenia and 27 sarcopenia. Sarcopenia was associated with lower energy (p = 0.020), total protein (p = 0.019), plant (p = 0.008) and fish proteins (p = 0.041), total fat (p = 0.015), monounsaturated fatty acids (MUFA) (p = 0.011), polyunsaturated fatty acids (p = 0.002), vitamin D intakes (p = 0.005) and, of fat quality indicators, MUFA: saturated fatty acid-ratio (p = 0.042).
Conclusion: These findings suggest that sufficient energy and protein intakes, but also fat quality may be important along with healthy dietary patterns for prevention of sarcopenia in the oldest-old.
Keywords: Fat quality; Macronutrient composition of the diet; Protein composition; Protein intake; Sarcopenia; Vitamin D.
Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Conflict of interest statement
Conflicts of interest SKJ: reports no conflict of interest. AU: reports no conflict of interest. MK: reports grants from NordForsk, the Academy of Finland, Helsinki Institute of Life Science and the Medical Research Council, UK, during the conduct of the study. TES: reports having various educational and consultative cooperation with several companies, including Nutricia, Abbott, Amgen, Merck, Pfizer, Novartis, and Novo-Nordisk; a minor amount of stock in Orion Pharma; and is a board member and former president of executive board of European Union Geriatric Medicine Society which has cooperation also with the nutrition industry.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical